Lidoxryl
Lidocaine · KIT · PureTek Corporation
Lidoxryl is a kit containing lidocaine. Manufactured by PureTek Corporation.
Key Facts
- Brand Name
- Lidoxryl
- Generic Name
- Lidocaine
- NDC Code (Product)
59088-722- Manufacturer
- PureTek Corporation
- Dosage Form
- KIT
- Marketing Status
- Marketing Start
- 10/23/2018
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
Dosage & Administration
DOSAGE AND ADMINISTRATION Apply lidocaine patch 5% to intact skin to cover the most painful area. Apply the prescribed number of patches (maximum of 3), only once for up to 12 hours within a 24-hour period. Patches may be cut into smaller sizes with scissors prior to removal of the release liner. (See HANDLING AND DISPOSAL ) Clothing may be worn over the area of application. Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination. If irritation or a burning sensation occurs during application, remove the patch(es) and do not reapply until the irritation subsides. When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered. Lidocaine patch 5% may not stick if it gets wet. Avoid contact with water, such as bathing, swimming or showering.
Warnings
WARNINGS Accidental Exposure in Children Even a used lidocaine patch contains a large amount of lidocaine (at least 665 mg). The potential exists for a small child or a pet to suffer serious adverse effects from chewing or ingesting a new or used lidocaine patch, although the risk with this formulation has not been evaluated. It is important for patients to store and dispose of lidocaine patch 5% out of the reach of children, pets and others. (See HANDLING AND DISPOSAL ) Excessive Dosing Excessive dosing by applying lidocaine patch 5% to larger areas or for longer than the recommended wearing time could result in increased absorption of lidocaine and high blood concentrations, leading to serious adverse effects (see ADVERSE REACTIONS , Systemic Reactions ). Lidocaine toxicity could be expected at lidocaine blood concentrations above 5 mcg/mL. The blood concentration of lidocaine is determined by the rate of systemic absorption and elimination. Longer duration of application, application of more than the recommended number of patches, smaller patients, or impaired elimination may all contribute to increasing the blood concentration of lidocaine. With recommended dosing of lidocaine …
Contraindications
CONTRAINDICATIONS Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.
Drug Interactions
Drug Interactions Antiarrhythmic Drugs: Lidocaine patch 5% should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the toxic effects are additive and potentially synergistic. Local Anesthetics: When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered.
Adverse Reactions
ADVERSE REACTIONS Application Site Reactions During or immediately after treatment with lidocaine patch 5%, the skin at the site of application may develop blisters, bruising, burning sensation, depigmentation, dermatitis, discoloration, edema, erythema, exfoliation, irritation, papules, petechia, pruritus, vesicles, or may be the locus of abnormal sensation. These reactions are generally mild and transient, resolving spontaneously within a few minutes to hours. Allergic Reactions Allergic and anaphylactoid reactions associated with lidocaine, although rare, can occur. They are characterized by angioedema, bronchospasm, dermatitis, dyspnea, hypersensitivity, laryngospasm, pruritus, shock, and urticaria. If they occur, they should be managed by conventional means. The detection of sensitivity by skin testing is of doubtful value. Other Adverse Events Due to the nature and limitation of spontaneous reports in postmarketing surveillance, causality has not been established for additional reported adverse events including: Asthenia, confusion, disorientation, dizziness, headache, hyperesthesia, hypoesthesia, lightheadedness, metallic taste, nausea, nervousness, pain exacerbated, paresth…
Frequently Asked Questions
What is Lidoxryl used for?
Lidoxryl contains Lidocaine. It is a kit taken as directed. Consult your doctor for specific uses.
Is Lidoxryl a controlled substance?
Lidoxryl is not classified as a controlled substance by the DEA.
What is the generic name for Lidoxryl?
The generic name for Lidoxryl is Lidocaine. There are 12 other brand versions of Lidocaine.
What is the NDC code for Lidoxryl ?
The NDC (National Drug Code) for Lidoxryl is 59088-722, listed by PureTek Corporation.
Other Lidocaine Brands
See all →- MAXOCAINE Topical Anesthetic Anorectal50 mg/mL72188-076
- MAXOCAINE Lidocaine Hemp Oil Topical Analgesic40 mg/mL72188-188
- LIDOCAINE50 mg/g72189-211
- INSTA RELIEF DM40 mg/mL72465-600
- Lidocaine Hydrochloride10 mg/mL72603-350
- Hemorrhoid Master40 mg/g72654-002
- DCH Nerve Pain Relief Roll-On4 g/100g72839-014
- DCH Pain Relief Roll-On4 g/100g72839-087
- FIRST SHIELD20 mg/mL72976-004
- Lidocaine Hydrochloride10 mg/mL73293-0001
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)